title: Comparative metabolism of clinically important precursors of N-desmethyldiazepam using phenobarbitone-pretreated rat liver microsomes.
abstract: Phenobarbitone-pretreated male Sprague-Dawley rat liver microsomes were used to examine C3-hydroxylation and N-dealkylation of four clinically important benzodiazepines: diazepam (DZP), prazepam (PZP), pinazepam (PIN) and halazepam (HZP). These substrates differ only in the nature of the N-substituent of the B ring and N-desmethyldiazepam (DMD) is the N-dealkylation product in each case. C3-Hydroxylation was accordingly also studied with DMD as substrate. All monooxygenations were studied with substrates at a concentration of 10 microM, in the absence of solubilizing agents, and under conditions where the production of secondary metabolites was minimized. A 20-fold variation in the rate of C3-hydroxylation was recorded across the five substrates with HZP showing the highest rate and DMD showing the lowest rate. An almost equally large range of variation was shown for the N-dealkylation reaction, with PZP undergoing this biotransformation more than 17 times faster than DZP. Log P values (a measure of lipophilicity) for the five substrates were determined using an HPLC method and a remarkable lack of correspondence between this substrate parameter and either of the monooxygenations was noted. This suggests that multiple substrate determinants govern the relative rates of these monooxygenations. It was, however, notable that the additive rate of metabolism of these substrates by both monooxygenase routes did show an excellent correlation with substrate lipophilicity.
authors.affiliation: Department of Medicine, University of Queensland, St Lucia, Queensland, Australia.
authors.forename: W D
authors.initials: WD
authors.lastname: Hooper
authors.forename: I
authors.initials: I
authors.lastname: Bruce
authors.forename: P E
authors.initials: PE
authors.lastname: Reilly
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000378:metabolism; D003975:Diazepam / Q000378:metabolism; D006900:Hydroxylation; D008297:Male; D008745:Methylation; D008862:Microsomes, Liver / Q000187:drug effects* / Q000378:metabolism; D003708:Nordazepam / Q000378:metabolism*; D010634:Phenobarbital / Q000494:pharmacology*; D011222:Prazepam / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013329:Structure-Activity Relationship
chemical_list: D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; C010175:halazepam; C010763:pinazepam; D003708:Nordazepam; D011222:Prazepam; D003975:Diazepam; D010634:Phenobarbital